Cart
sales@molnova.com
[D-Phe7]-Bradykinin
CAS No. 97825-00-8
[D-Phe7]-Bradykinin( ——— )
Catalog No. M40914 CAS No. 97825-00-8
[D-Phe7]-Bradykinin
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name[D-Phe7]-Bradykinin
-
NoteResearch use only, not for human use.
-
Brief Description[D-Phe7]-Bradykinin
-
Description[D-Phe7]-Bradykinin
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number97825-00-8
-
Formula Weight1110.29
-
Molecular FormulaC54H75N15O11
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
VIP (10-28) (human, ...
VIP (10-28) (human, bovine, porcine, rat)
-
LtaS-IN-1
LtaS-IN-1 is an effective inhibitor of Lipoteichoic acid synthesis in multidrug-resistant (MDR) E. faecium and by altering the cell wall morphology.
-
Kazinol B
Kazinol B, a prenylated flavan with a dimethyl pyrane ring, is an inhibitor of nitric oxide (NO) production. Kazinol B improves insulin sensitivity by enhancing glucose uptake via the insulin-Akt signaling pathway and AMPK activation. Kazinol B has the potential for diabetes mellitus research.
